These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22388572)

  • 1. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.
    Ram R; Wolach O; Vidal L; Gafter-Gvili A; Shpilberg O; Raanani P
    Am J Hematol; 2012 May; 87(5):472-8. PubMed ID: 22388572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
    Guzauskas GF; Villa KF; Vanhove GF; Fisher VL; Veenstra DL
    J Adolesc Young Adult Oncol; 2017 Mar; 6(1):53-61. PubMed ID: 27779442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis.
    Ram R; Gafter-Gvili A; Vidal L; Paul M; Ben-Bassat I; Shpilberg O; Raanani P
    Cancer; 2010 Jul; 116(14):3447-57. PubMed ID: 20564092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
    Ribera JM; Morgades M; Montesinos P; Tormo M; Martínez-Carballeira D; González-Campos J; Gil C; Barba P; García-Boyero R; Coll R; Pedreño M; Ribera J; Mercadal S; Vives S; Novo A; Genescà E; Hernández-Rivas JM; Bergua J; Amigo ML; Vall-Llovera F; Martínez-Sánchez P; Calbacho M; García-Cadenas I; Garcia-Guiñon A; Sánchez-Sánchez MJ; Cervera M; Feliu E; Orfao A;
    Cancer Med; 2020 Apr; 9(7):2317-2329. PubMed ID: 32022463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute lymphoblastic leukemia in adolescents and young adults].
    Hayakawa F
    Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of adult acute lymphoblastic leukemia in the era of pediatric-inspired regimens: a single-center experience.
    Tantiworawit A; Rattanathammethee T; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L
    Int J Hematol; 2019 Sep; 110(3):295-305. PubMed ID: 31161483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.
    Hanbali A; Kotb A; El Fakih R; Alfraih F; Ahmed SO; Shaheen M; Hashmi S; Alhayli S; Alahmari A; Riash MA; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M
    Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):670-677. PubMed ID: 31377206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.
    White VM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Orme LM; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27349. PubMed ID: 30039912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.
    Jaime-Pérez JC; Jiménez-Castillo RA; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Marfil-Rivera LJ; Gómez-Almaguer D
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
    Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL
    Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults].
    Yamazaki E
    Rinsho Ketsueki; 2022; 63(7):826-832. PubMed ID: 35922954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia in adolescents and young adults.
    Burke PW; Douer D
    Acta Haematol; 2014; 132(3-4):264-73. PubMed ID: 25228551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
    J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Two Pediatric-Inspired Regimens to Hyper-CVAD in Hispanic Adolescents and Young Adults With Acute Lymphoblastic Leukemia.
    Almanza-Huante E; Espinosa-Bautista K; Rangel-Patiño J; Demichelis-Gómez R
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):55-62.e2. PubMed ID: 32893130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Ribera JM; García O; Gil C; Mercadal S; García-Cadenas I; Montesinos P; Barba P; Vives S; González-Campos J; Tormo M; Esteve J; López A; Moreno MJ; Ribera J; Alonso N; Bermúdez A; Amigo ML; Genescà E; García D; Vall-Llovera F; Bergua JM; Guàrdia R; Monteserín MC; Bernal T; Calbacho M; Martínez MP; Feliu E;
    Leuk Res; 2018 May; 68():79-84. PubMed ID: 29574396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
    López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
    Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
    Rytting ME; Jabbour EJ; Jorgensen JL; Ravandi F; Franklin AR; Kadia TM; Pemmaraju N; Daver NG; Ferrajoli A; Garcia-Manero G; Konopleva MY; Borthakur G; Garris R; Wang S; Pierce S; Schroeder K; Kornblau SM; Thomas DA; Cortes JE; O'Brien SM; Kantarjian HM
    Am J Hematol; 2016 Aug; 91(8):819-23. PubMed ID: 27178680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
    Siegel SE; Stock W; Johnson RH; Advani A; Muffly L; Douer D; Reed D; Lewis M; Freyer DR; Shah B; Luger S; Hayes-Lattin B; Jaboin JJ; Coccia PF; DeAngelo DJ; Seibel N; Bleyer A
    JAMA Oncol; 2018 May; 4(5):725-734. PubMed ID: 29450465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemia.
    Kliman D; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Narayanan S; Nevill T; Power M; Sanford D; Song K; Sutherland H; Toze C; Abou Mourad Y
    Leuk Lymphoma; 2017 Apr; 58(4):909-915. PubMed ID: 27561638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.